Human Metabolome Technologies Inc
TSE:6090
Human Metabolome Technologies Inc
Income from Continuing Operations
Human Metabolome Technologies Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Human Metabolome Technologies Inc
TSE:6090
|
Income from Continuing Operations
¥282.6m
|
CAGR 3-Years
64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Income from Continuing Operations
¥5.6B
|
CAGR 3-Years
63%
|
CAGR 5-Years
30%
|
CAGR 10-Years
15%
|
|
Medinet Co Ltd
TSE:2370
|
Income from Continuing Operations
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
CellSource Co Ltd
TSE:4880
|
Income from Continuing Operations
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Income from Continuing Operations
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Income from Continuing Operations
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Human Metabolome Technologies Inc's Income from Continuing Operations?
Income from Continuing Operations
282.6m
JPY
Based on the financial report for Dec 31, 2023, Human Metabolome Technologies Inc's Income from Continuing Operations amounts to 282.6m JPY.
What is Human Metabolome Technologies Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
64%
Over the last year, the Income from Continuing Operations growth was 9%. The average annual Income from Continuing Operations growth rates for Human Metabolome Technologies Inc have been 64% over the past three years .